April’s top stories: CN Bio licenced Hepatitis B drug programme, Astellas agreed to acquire Ogeda for €800m

1
A research campus operated by Bristol-Myers Squibb in Princeton, New Jersey. Photo: courtesy of Coolcaesar at the English language Wikipedia.